Quantcast

Latest Boston Scientific Corporation Stories

2014-05-15 04:22:35

PARIS, May 15, 2014 /PRNewswire/ -- Boston Scientific Reinforces Its Commitment to Global Education and Innovation Boston Scientific Corporation (NYSE:BSX) celebrated the opening of a new facility dedicated to endoscopy training within its Institute for Advancing Science in Paris. The ceremony included major representatives of the endoscopy medical community in Europe. Endoscopy professional training and education is...

2014-05-10 16:21:17

PREDICt-RM Collaborative Study between Boston Scientific, American College of Cardiology and Yale University Highlights Improved Outcomes in ICD and CRT-D Patients followed with the LATITUDE(TM) System NATICK, Mass., May 10, 2014 /PRNewswire/ -- Patients using the Boston Scientific Corporation (NYSE: BSX) LATITUDE(TM) Remote Patient Management system with wireless telemetry demonstrated significantly lower mortality and fewer hospitalizations than patients with LATITUDE-compatible...

2014-05-08 16:28:07

Boston Scientific Shockless Implant Evaluation (SIMPLE) Study Results Presented at Heart Rhythm 2014, the Heart Rhythm Society's 35th Annual Scientific Sessions NATICK, Mass., May 8, 2014 /PRNewswire/ -- A Boston Scientific Corporation (NYSE: BSX) study demonstrated that outcomes for patients with the company's transvenous implantable cardioverter defibrillators (ICD) who received routine defibrillation testing (DT) at implant were similar to outcomes for those patients who did not...

2014-05-08 04:21:45

Advanced Illumina(TM) 3D Programming Software Provides Highly Significant Pain Relief in Study Patients NATICK, Mass., May 8, 2014 /PRNewswire/ -- New retrospective data highlighting the Boston Scientific Corporation (NYSE: BSX) Precision Spectra(TM) Spinal Cord Stimulator (SCS) System demonstrate the device provided sustained and highly significant relief of low-back pain six months after implantation. Results were presented at the World Institute of Pain (WIP) 7(th) World Congress in...

2014-05-06 16:33:48

Innovative Technology Designed to Treat Intrauterine Fibroids and Polyps NATICK, Mass. and CUPERTINO, Calif., May 6, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has signed a definitive agreement to acquire IoGyn, Inc., a pre-commercial stage company. The transaction is expected to close within days. IoGyn has developed and received U.S. Food and Drug Administration (FDA) clearance for the Symphion(TM) System, a next generation system for hysteroscopic...

2014-05-06 08:33:21

Global medical solutions innovator seeks to pioneer new research into effective treatments for heart failure and related cardiac conditions NATICK, Mass., May 6, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) has joined Optum Labs as the Founding Medical Device Partner to help pioneer new research into effective treatments for heart failure and related cardiac conditions. Optum Labs is an open collaborative healthcare research and innovation center founded in 2013...

2014-05-01 08:37:26

Promising Clinical Data to be Presented at Annual Conference NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will present select abstracts and clinical data analyses pertaining to key issues in gastroenterology during Digestive Disease Week (DDW(®)) 2014, May 4-6 in Chicago. Data presentations will include the Boston Scientific SpyGlass((TM)) Direct Visualization System, the Resolution((TM)) Clip and the recently FDA cleared and CE marked...

2014-05-01 08:36:48

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Bank of America Merrill Lynch 2014 Healthcare Conference on May 13 in Las Vegas, NV. Susie Lisa, vice president, Investor Relations, will participate in a 30-minute question and answer session regarding the company beginning at approximately 5:00 p.m. PT. A live webcast of the question and answer session will be available to interested parties via the Boston...

2014-05-01 00:21:42

NATICK, Mass., May 1, 2014 /PRNewswire/ -- Continuing to advance leading drug-eluting stent (DES) technology, Boston Scientific Corporation (NYSE: BSX) has launched the Promus PREMIER(TM) Everolimus-Eluting Platinum Chromium Coronary Stent System in Japan. This advanced DES system recently received Japan Ministry of Health, Labor and Welfare (MHLW) approval. "It is my great pleasure to be able to provide the Promus PREMIER(TM) Stent System to physicians and patients in Japan,"...

2014-04-29 08:34:19

Company Exceeds Earnings Per Share Guidance on the Strength of Continued Revenue Growth NATICK, Mass., April 29, 2014 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) generated sales of $1.774 billion during the first quarter ended March 31, 2014. This represents 4 percent operational revenue growth (constant currency basis, excluding divested businesses) and 1 percent revenue growth on a reported basis, all compared to the prior year period. The company also achieved adjusted...


Word of the Day
negawatt
  • A unit of saved energy.
Coined by Amory Lovins, chairman of the Rocky Mountain Institute as a contraction of negative watt on the model of similar compounds like megawatt.